Xu-Chao Zhang Selected Research

Xu-Chao Zhang Research Topics

Disease

45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 12/2009
33	Neoplasms (Cancer) 01/2022 - 09/2007
30	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2007
8	Adenocarcinoma of Lung 01/2021 - 01/2012
7	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2017
5	Adenocarcinoma 11/2019 - 05/2010
3	Carcinoma (Carcinomatosis) 01/2020 - 09/2007
2	Sarcoma (Soft Tissue Sarcoma) 10/2021 - 07/2014
2	Disease Progression 01/2018 - 01/2017
2	Carcinogenesis 01/2016 - 08/2012
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Malignant Pleural Effusion 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Carcinoid Tumor (Carcinoid) 12/2021
1	Adenocarcinoma in Situ 11/2019
1	Solitary Pulmonary Nodule 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2015
1	Lymphatic Metastasis 07/2015
1	Neuroblastoma 07/2014
1	Lymphoma (Lymphomas) 03/2014
1	Neutropenia 06/2012
1	Esophageal Neoplasms (Esophageal Cancer) 01/2012
1	Rare Diseases (Rare Disease) 01/2012
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2010
1	Leukemia 01/2008
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2008

Drug/Important Bio-Agent (IBA)

29	ErbB Receptors (EGF Receptor)IBA 11/2021 - 12/2009
25	Tyrosine Kinase InhibitorsIBA 11/2022 - 12/2009
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2007
8	Gefitinib (Iressa)FDA Link 11/2021 - 01/2011
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
6	Anaplastic Lymphoma KinaseIBA 01/2020 - 03/2014
6	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2011
5	CrizotinibIBA 11/2018 - 03/2014
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2016
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2007
2	osimertinibIBA 01/2022 - 01/2018
2	Biological ProductsIBA 01/2022 - 02/2016
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021 - 07/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020 - 03/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019 - 12/2014
2	B7-H1 AntigenIBA 11/2019 - 11/2018
2	Gemcitabine FDA Link 01/2019 - 03/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 01/2016
2	IGF-I-IGFBP-3 complex FDA Link 06/2017 - 03/2016
2	Phosphotransferases (Kinase)IBA 03/2014 - 09/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2011 - 01/2011
1	Pharmaceutical PreparationsIBA 01/2022
1	icotinibIBA 12/2021
1	Tyrosine (L-Tyrosine)FDA Link 12/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2021
1	pembrolizumabIBA 01/2021
1	Protons (Proton)IBA 07/2020
1	sotorasibIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	abivertinibIBA 05/2019
1	Complementary DNA (cDNA)IBA 12/2017
1	LigandsIBA 06/2017
1	PlatinumIBA 01/2017
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	Adiponectin ReceptorsIBA 07/2015
1	Carcinoembryonic AntigenIBA 07/2015
1	TensinsIBA 07/2014
1	human ERBB2 proteinIBA 07/2014
1	Class Ia Phosphatidylinositol 3-KinaseIBA 07/2014
1	MAP Kinase Kinase 1IBA 07/2014
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2013
1	Everolimus FDA Link 11/2012
1	ORALIT (ORS)IBA 10/2012
1	KalininIBA 08/2012
1	Extracellular Matrix ProteinsIBA 08/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Hemoglobins (Hemoglobin)IBA 06/2012
1	Bevacizumab (Avastin)FDA Link 06/2012
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 09/2011
1	VaccinesIBA 01/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2007

Therapy/Procedure

15	Therapeutics 01/2022 - 09/2007
10	Drug Therapy (Chemotherapy) 12/2021 - 03/2010
6	Immunotherapy 10/2021 - 06/2017
2	Lasers (Laser) 06/2017 - 03/2016
2	Precision Medicine 01/2017 - 03/2014
2	Thoracotomy 07/2015 - 05/2010
1	Aftercare (After-Treatment) 01/2021
1	Neoadjuvant Therapy 01/2019
1	Operative Surgical Procedures 01/2018